Prosthetic

ContraFect Announces Publication on Exebacase and CF-296 Demonstrating Potent In Vivo Antimicrobial Activity in Implant-Associated MRSA Osteomyelitis

YONKERS, N.Y., Aug. 15, 2022 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq: CFRX), a clinical-stage biotechnology company focused on the discovery…

2 years ago

ReWalk Robotics Reports Second Quarter 2022 Financial Results

Highlights June 8th Milestone Participation at Biannual CMS HCPCS Public Meeting as Part of Efforts to Gain “Artificial Legs” Benefit…

2 years ago

Luke the Bionic Arm is Helping Amputees Feel Whole Again

Scientists have developed another remarkable innovation that’s helping amputees gain a new lease on life. Once again, researchers have developed…

5 years ago